Mauro D'Amato

Professor of Medical Gentics

LUM Jean Monnet University

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (20)

Collaborators (23)

Jonas Halfvarson

Örebro universitet Institutionen för medicinska vetenskaper

Laura Stronati

Full Professor

Sapienza University of Rome

Emma Vincent

University of Bristol

UNITED KINGDOM

Nicholas Timpson

University of Bristol

UNITED KINGDOM

Isabella Friis Jørgensen

Københavns Universitet

David Ellinghaus

Kiel University

James Lee

The Francis Crick Institute

UNITED KINGDOM

Michael Forster

Kiel University

Robert Kruse

Associated Professor

Örebro university

Tobias Gräßle

Robert Koch Institute

Michel Georges

University of Liege

Johan Van Limbergen

Amsterdam University Medical Centers

J. Tack

Elin Org

Sven Almer

Karolinska Institutet

Christian Tomuschat

University Medical Center Hamburg-Eppendorf

Mohamed Nseir

Lund University

Britta F. Zecher

University Medical Center Hamburg-Eppendorf

Debby Laukens

Associate Professor

Ghent University

Hassan Y. Naim

University of Veterinary Medicine Hannover, Foundation

Carolina Medina-Gomez

Daniel D. Buchanan

University of Melbourne

Bodil Ohlsson

Lund University

Mauro D'Amato

Research Interests

Explore related searches

Contact this professor

Articles (20)

Mendelian randomisation shows diverticular disease and irritable bowel syndrome increase the risk of haemorrhoidal disease

A Starch- and Sucrose-Reduced Diet Has Similar Efficiency as Low FODMAP in IBS—A Randomized Non-Inferiority Study

Human CAZyme genes polymorphism and risk of IBS: a population-based study

Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome

Circulating white blood cell traits and colorectal cancer risk

Genetic analyses of treatment response in primary care IBS, a pilot study

HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44<sup>+</sup> Natural Killer Cells in Ulcerative Colitis.

Genetic Variants as Predictors of the Success of Colorectal Cancer Treatments

Faecal biomarkers of neutrophil and eosinophil origin reflect the response to biological therapy and corticosteroids in patients with IBD

Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis

Adult sucrase-isomaltase deficiency masquerading as IBS

Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies

Performance of the Use of Genetic Information to Assess the Risk of Colorectal Cancer in the Basque Population

Genome-wide analysis of 944 133 individuals provides insights into the etiology of haemorrhoidal disease

Association Between Collagenous and Lymphocytic Colitis and Risk of Severe Coronavirus Disease 2019

Large-scale association analyses identify host factors influencing human gut microbiome composition.

Gastrointestinal Infection and Risk of Microscopic Colitis: A Nationwide Case-Control Study in Sweden.

Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes

Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes

Microscopic colitis

Collaborators (23)

Jonas Halfvarson

Laura Stronati

Emma Vincent

Nicholas Timpson

Isabella Friis Jørgensen

David Ellinghaus

James Lee

Michael Forster

Robert Kruse

Tobias Gräßle

Michel Georges

Johan Van Limbergen

J. Tack

Elin Org

Sven Almer

Christian Tomuschat

Mohamed Nseir

Britta F. Zecher

Debby Laukens

Hassan Y. Naim

Carolina Medina-Gomez

Daniel D. Buchanan

Bodil Ohlsson

How do I reach out?

Meet Kite AI